β-Hydroxybutyrate in Cardiovascular Diseases : A Minor Metabolite of Great Expectations

Despite recent advances in therapies, cardiovascular diseases ( CVDs ) are still the leading cause of mortality worldwide. Previous studies have shown that metabolic perturbations in cardiac energy metabolism are closely associated with the progression of CVDs. As expected, metabolic interventions c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Shao, Binbin, Liu, Yuan, Wu, Zhong, Zhang, Donghai, Lin, Caihua, Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234267/
https://www.ncbi.nlm.nih.gov/pubmed/35769904
http://dx.doi.org/10.3389/fmolb.2022.823602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234267/
https://www.ncbi.nlm.nih.gov/pubmed/35769904
http://dx.doi.org/10.3389/fmolb.2022.823602

Ejemplares similares